Tigatuzumab Antibody
Tigatuzumab (CS-1008) is a humanized agonistic monoclonal antibody targeting Death Receptor 5 (DR5/TRAIL-R2) to induce apoptosis in tumor cells. It has been investigated in preclinical and clinical studies, particularly for pancreatic cancer research, demonstrating activity in both in vitro and in vivo models.
Product Specifications
Product Name Alternative
Anti-Human TRAIL-R2 Recombinant Antibody, CS1008, CS-1008, TRA8, TRA-8
Target
TNF, Apoptosis
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cell Biology
Concentration
9.15 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
144.63 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC740226-500 1x 500 µL
Pmel17 / gp100 / SILV (NKI-beteb), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040391-500 1x 500 µL
CD81 / TAPA-1 (1.3.3.22), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC472452-100 1x 100 µL
HER-2 / c-erbB-2 / neu / CD340 (ERBB2/2452), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680525-500 1x 500 µL
CD63 (MX-49.129.5), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 